Literature DB >> 17585098

Protein metabolism in preterm infants with particular reference to intrauterine growth restriction.

H A de Boo1, J E Harding.   

Abstract

There is growing evidence that neonatal and long-term morbidity in preterm infants, particularly those born before 32 weeks' gestation, can be modified by attained growth rate in the neonatal period. Guidelines for optimal growth and the nutritional intakes, particular of protein, required to achieve this are not well defined. Due to delays in postnatal feeding and a lack of energy stores developed in the last trimester of pregnancy, preterm infants often suffer early postnatal catabolism until feeding is established. There are indications that infants born with intrauterine growth restriction have perturbations in protein metabolism. Therefore, they may have different protein requirements than appropriate for gestational age infants. This review summarises what is known about protein requirements and metabolism in the fetus and preterm infant, with particular emphasis on the distinct requirements of the growth-restricted infant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585098      PMCID: PMC2675441          DOI: 10.1136/adc.2006.099697

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  57 in total

1.  Metabolic differences between AGA- and SGA-infants of very low birthweight. I. Relationship to intrauterine growth retardation.

Authors:  G Boehm; H Senger; W Braun; K Beyreiss; N C Räihä
Journal:  Acta Paediatr Scand       Date:  1988-01

2.  Ammonia production by the pregnant uterus (39868).

Authors:  I R Holzman; J A Lemons; G Meschia; F C Battaglia
Journal:  Proc Soc Exp Biol Med       Date:  1977-10

3.  Umbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero.

Authors:  I Cetin; A M Marconi; P Bozzetti; L P Sereni; C Corbetta; G Pardi; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

4.  Energy-nitrogen balances and protein turnover in small and appropriate for gestational age low birthweight infants.

Authors:  M Cauderay; Y Schutz; J L Micheli; A Calame; E Jéquier
Journal:  Eur J Clin Nutr       Date:  1988-02       Impact factor: 4.016

5.  Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic l-amino acids: a preliminary report.

Authors:  W C Heird; J F Nicholson; J M Driscoll; J N Schullinger; R W Winters
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

6.  Metabolic acidosis resulting from intravenous alimentation mixtures containing synthetic amino acids.

Authors:  W C Heird; R B Dell; J M Driscoll; B Grebin; R W Winters
Journal:  N Engl J Med       Date:  1972-11-09       Impact factor: 91.245

7.  Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

Authors:  M Msall; M L Batshaw; R Suss; S W Brusilow; E D Mellits
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

8.  Total-body protein turnover in human premature neonates: effects of birth weight, intra-uterine nutritional status and diet.

Authors:  P B Pencharz; M Masson; F Desgranges; A Papageorgiou
Journal:  Clin Sci (Lond)       Date:  1981-08       Impact factor: 6.124

9.  Metabolic differences between AGA- and SGA-infants of very low birthweight. II. Relationship to protein intake.

Authors:  G Boehm; H Senger; D Müller; K Beyreiss; N C Räihä
Journal:  Acta Paediatr Scand       Date:  1988-09

10.  Nitrogen metabolism in preterm infants fed human donor breast milk: the possible essentiality of glycine.

Authors:  A A Jackson; J C Shaw; A Barber; M H Golden
Journal:  Pediatr Res       Date:  1981-11       Impact factor: 3.756

View more
  7 in total

1.  The Impact of Neonatal Illness on Nutritional Requirements-One Size Does Not Fit All.

Authors:  Sara E Ramel; Laura D Brown; Michael K Georgieff
Journal:  Curr Pediatr Rep       Date:  2014-12

2.  Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells.

Authors:  Jixiu Shan; Maria-Cecilia Lopez; Henry V Baker; Michael S Kilberg
Journal:  Physiol Genomics       Date:  2010-03-09       Impact factor: 3.107

3.  The effects of early parenteral amino acids on sick premature infants.

Authors:  Ruth Heimler; Janine M Bamberger; Ponthenkandath Sasidharan
Journal:  Indian J Pediatr       Date:  2010-09-10       Impact factor: 1.967

4.  Effect of increased enteral protein intake on plasma and urinary urea concentrations in preterm infants born at < 32 weeks gestation and < 1500 g birth weight enrolled in a randomized controlled trial - a secondary analysis.

Authors:  Michaela Mathes; Christoph Maas; Christine Bleeker; Julia Vek; Wolfgang Bernhard; Andreas Peter; Christian F Poets; Axel R Franz
Journal:  BMC Pediatr       Date:  2018-05-08       Impact factor: 2.125

5.  Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction.

Authors:  Ray Oliver Bahado-Singh; Ali Yilmaz; Halil Bisgin; Onur Turkoglu; Praveen Kumar; Eric Sherman; Andrew Mrazik; Anthony Odibo; Stewart F Graham
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

Review 6.  Dimming the Powerhouse: Mitochondrial Dysfunction in the Liver and Skeletal Muscle of Intrauterine Growth Restricted Fetuses.

Authors:  Alexander L Pendleton; Stephanie R Wesolowski; Timothy R H Regnault; Ronald M Lynch; Sean W Limesand
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

7.  Assessment of catabolic state in infants with the use of urinary titin N-fragment.

Authors:  Sachiyo Fukushima; Nobuto Nakanishi; Kazumichi Fujioka; Kenichi Suga; Taku Shirakawa; Kayo Osawa; Kanako Hara; Rie Tsutsumi; Maki Urushihara; Ryuji Nakagawa; Hiroyuki Awano; Jun Oto; Hiroshi Sakaue; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Res       Date:  2021-07-17       Impact factor: 3.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.